Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:collaboratesWith |
local healthcare providers
government health initiatives |
| gptkbp:contributedTo |
local healthcare improvements
|
| gptkbp:distributes |
medications_across_Asia
|
| gptkbp:employs |
over 1,000 people
|
| gptkbp:focusesOn |
biotechnology
generic pharmaceuticals branded pharmaceuticals |
| gptkbp:hasHistoricalSignificance |
gptkb:Shanghai
|
| gptkbp:hasPartnershipsWith |
international pharmaceutical companies
|
| gptkbp:hasResearchInterest |
facilities_in_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lupin China
|
| gptkbp:isKnownFor |
affordable medications
innovative drug delivery systems high-quality generics |
| gptkbp:isRegulatedBy |
National_Medical_Products_Administration_(NMPA)
|
| gptkbp:isSymbolicOf |
gptkb:Lupin_Limited
|
| gptkbp:offers |
antibiotics
cardiovascular drugs diabetes medications central nervous system drugs |
| gptkbp:operatesIn |
gptkb:China
|
| gptkbp:partOf |
gptkb:Lupin_Limited
|
| gptkbp:wasFoundedIn |
2004
|